These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 17229101

  • 1. Monoamine oxidase A rather than monoamine oxidase B inhibition increases nicotine reinforcement in rats.
    Guillem K, Vouillac C, Azar MR, Parsons LH, Koob GF, Cador M, Stinus L.
    Eur J Neurosci; 2006 Dec; 24(12):3532-40. PubMed ID: 17229101
    [Abstract] [Full Text] [Related]

  • 2. MAO-B knockout mice exhibit deficient habituation of locomotor activity but normal nicotine intake.
    Lee M, Chen K, Shih JC, Hiroi N.
    Genes Brain Behav; 2004 Aug; 3(4):216-27. PubMed ID: 15248867
    [Abstract] [Full Text] [Related]

  • 3. L-methamphetamine and selective MAO inhibitors decrease morphine-reinforced and non-reinforced behavior in rats; Insights towards selegiline's mechanism of action.
    He S, Grasing K.
    Pharmacol Biochem Behav; 2006 Dec; 85(4):675-88. PubMed ID: 17157368
    [Abstract] [Full Text] [Related]

  • 4. Irreversible blockade of monoamine oxidases reveals the critical role of 5-HT transmission in locomotor response induced by nicotine in mice.
    Villégier AS, Salomon L, Blanc G, Godeheu G, Glowinski J, Tassin JP.
    Eur J Neurosci; 2006 Sep; 24(5):1359-65. PubMed ID: 16965547
    [Abstract] [Full Text] [Related]

  • 5. Monoamine oxidase inhibitors allow locomotor and rewarding responses to nicotine.
    Villégier AS, Salomon L, Granon S, Changeux JP, Belluzzi JD, Leslie FM, Tassin JP.
    Neuropsychopharmacology; 2006 Aug; 31(8):1704-13. PubMed ID: 16395299
    [Abstract] [Full Text] [Related]

  • 6. The monoamine oxidase inhibitor phenelzine enhances the discriminative stimulus effect of nicotine in rats.
    Wooters TE, Bardo MT.
    Behav Pharmacol; 2007 Nov; 18(7):601-8. PubMed ID: 17912044
    [Abstract] [Full Text] [Related]

  • 7. Human monoamine oxidase is inhibited by tobacco smoke: beta-carboline alkaloids act as potent and reversible inhibitors.
    Herraiz T, Chaparro C.
    Biochem Biophys Res Commun; 2005 Jan 14; 326(2):378-86. PubMed ID: 15582589
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of MAO-A activity enhances behavioural activity of rats assessed using water maze and open arena tasks.
    Barbelivien A, Nyman L, Haapalinna A, Sirviö J.
    Pharmacol Toxicol; 2001 Jun 14; 88(6):304-12. PubMed ID: 11453370
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of monoamine oxidase isoforms modulates nicotine withdrawal syndrome in the rat.
    Malin DH, Moon WD, Goyarzu P, Barclay E, Magallanes N, Vela AJ, Negrete AP, Mathews H, Stephens B, Mills WR.
    Life Sci; 2013 Oct 06; 93(12-14):448-53. PubMed ID: 23988853
    [Abstract] [Full Text] [Related]

  • 10. [A behavioral and neurochemical study on the mechanism of the anxiolytic effect of monoamine oxidase inhibitors].
    Maki Y.
    Hokkaido Igaku Zasshi; 2001 May 06; 76(3):133-42. PubMed ID: 11481866
    [Abstract] [Full Text] [Related]

  • 11. Platelet monoamine oxidase, smoking cessation, and tobacco withdrawal symptoms.
    Rose JE, Behm FM, Ramsey C, Ritchie JC.
    Nicotine Tob Res; 2001 Nov 06; 3(4):383-90. PubMed ID: 11694206
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Monoamine oxidase inhibition dramatically prolongs the duration of nicotine withdrawal-induced place aversion.
    Guillem K, Vouillac C, Koob GF, Cador M, Stinus L.
    Biol Psychiatry; 2008 Jan 15; 63(2):158-63. PubMed ID: 17643399
    [Abstract] [Full Text] [Related]

  • 14. Reinforcing and neural activating effects of norharmane, a non-nicotine tobacco constituent, alone and in combination with nicotine.
    Arnold MM, Loughlin SE, Belluzzi JD, Leslie FM.
    Neuropharmacology; 2014 Oct 15; 85():293-304. PubMed ID: 24907588
    [Abstract] [Full Text] [Related]

  • 15. Effect of co-administration of subchronic lithium pretreatment and acute MAO inhibitors on extracellular monoamine levels and the expression of contextual conditioned fear in rats.
    Kitaichi Y, Inoue T, Nakagawa S, Izumi T, Koyama T.
    Eur J Pharmacol; 2006 Feb 27; 532(3):236-45. PubMed ID: 16487506
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Isolation and characterization of a monoamine oxidase B selective inhibitor from tobacco smoke.
    Khalil AA, Davies B, Castagnoli N.
    Bioorg Med Chem; 2006 May 15; 14(10):3392-8. PubMed ID: 16458520
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.